TY - JOUR
T1 - Alterations in glomerular dynamics in congenital, unilateral hydronephrosis
AU - Hanss, Basil G.
AU - Lewy, John E.
AU - Vari, Richard C.
N1 - Funding Information:
This research was supported by a grant from the March of Dimes to R.C. Van under the Basil O'Connor Scholar Research Program. Stipend support for B.G. Hanss was provided by the American Heart Association, Louisiana Inc., Graduate Student Fellowship Program. The authors thank Shane Valencia for providing technical support. Portions of this study were published in abstract form (JASN 3:563, 1993).
PY - 1994/7
Y1 - 1994/7
N2 - We have previously shown that rats with congenital, unilateral hydronephrosis exhibit a reduction in GFR that returns to normal when either the renin angiotensin system or thromboxane A2 (TxA2) is blocked. The current study defines the single nephron defect in congenital, unilateral hydronephrosis and evaluates the roles of angiotensin II (Ang II) and TxA2 in this renal derangement. Renal micropuncture experiments were performed on the right kidney of rats from an inbred colony with unilateral right-sided hydronephrosis (HYDRO), or nonaffected litter mates (CONTROL). In addition, four separate groups of hydronephrotic animals were treated with either the TxA2 receptor antagonist SQ-29548 (SQ), one of two Ang II receptor antagonists [saralasin (SAR) or DuP-753 (DUP)], or combined treatment with DuP-753 and SQ-29,548 (SandD). SNGFR was significantly reduced (P < 0.05) in HYDRO compared to CONTROL (17.6 ± 2.0 vs. 35.9 ± 3.7 nl/min, respectively). Treatment with SQ-29,548 normalized SNGFR (29.0 ± 3.0 nl/min), while saralasin and DuP-753 resulted in only a partial recovery of function (25.6 ± 1.6 and 27.8 ± 1.4 nl/min, respectively). Combined SQ-29,548 and DuP-753 treatment resulted in full recovery of SNGFR to 32.9 ± 4.4 nl/min. The glomerular ultrafiltration coefficient (K(f)) was reduced (P < 0.05) approximately 45% in HYDRO compared to CONTROL (1.64 ±.08 vs. 2.84 ± .22 nl/min/mm Hg, respectively). K(f) returned to control levels in SAR, DUP and SQ, and increased above control in SandD (5.58 ± 1.6 nl/min/mm Hg). There were no differences (P > 0.05) in hydrostatic or oncotic pressures across the glomerular capillary between any of the groups studied. The observation that K(f) increases above CONTROL with combined blockade of TxA2 and Ang II suggests that these regulatory hormones decrease K(f) via independent mechanisms. These data indicate that the reduction in SNGFR in congenital, unilateral hydronephrosis is a result of a marked fall in K(f) that is mediated by both Ang II and TxA2.
AB - We have previously shown that rats with congenital, unilateral hydronephrosis exhibit a reduction in GFR that returns to normal when either the renin angiotensin system or thromboxane A2 (TxA2) is blocked. The current study defines the single nephron defect in congenital, unilateral hydronephrosis and evaluates the roles of angiotensin II (Ang II) and TxA2 in this renal derangement. Renal micropuncture experiments were performed on the right kidney of rats from an inbred colony with unilateral right-sided hydronephrosis (HYDRO), or nonaffected litter mates (CONTROL). In addition, four separate groups of hydronephrotic animals were treated with either the TxA2 receptor antagonist SQ-29548 (SQ), one of two Ang II receptor antagonists [saralasin (SAR) or DuP-753 (DUP)], or combined treatment with DuP-753 and SQ-29,548 (SandD). SNGFR was significantly reduced (P < 0.05) in HYDRO compared to CONTROL (17.6 ± 2.0 vs. 35.9 ± 3.7 nl/min, respectively). Treatment with SQ-29,548 normalized SNGFR (29.0 ± 3.0 nl/min), while saralasin and DuP-753 resulted in only a partial recovery of function (25.6 ± 1.6 and 27.8 ± 1.4 nl/min, respectively). Combined SQ-29,548 and DuP-753 treatment resulted in full recovery of SNGFR to 32.9 ± 4.4 nl/min. The glomerular ultrafiltration coefficient (K(f)) was reduced (P < 0.05) approximately 45% in HYDRO compared to CONTROL (1.64 ±.08 vs. 2.84 ± .22 nl/min/mm Hg, respectively). K(f) returned to control levels in SAR, DUP and SQ, and increased above control in SandD (5.58 ± 1.6 nl/min/mm Hg). There were no differences (P > 0.05) in hydrostatic or oncotic pressures across the glomerular capillary between any of the groups studied. The observation that K(f) increases above CONTROL with combined blockade of TxA2 and Ang II suggests that these regulatory hormones decrease K(f) via independent mechanisms. These data indicate that the reduction in SNGFR in congenital, unilateral hydronephrosis is a result of a marked fall in K(f) that is mediated by both Ang II and TxA2.
UR - https://www.scopus.com/pages/publications/0028366141
U2 - 10.1038/ki.1994.243
DO - 10.1038/ki.1994.243
M3 - Article
C2 - 7933848
AN - SCOPUS:0028366141
SN - 0085-2538
VL - 46
SP - 48
EP - 57
JO - Kidney International
JF - Kidney International
IS - 1
ER -